Physical Activity Program with Peer Support for Men with Prostate Cancer
Randomized Study to Improve Exercise and Health Outcomes
Led by Centre Hospitalier Universitaire de Saint Etienne · Updated on 2025-11-24
850
Participants Needed
25
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a physical activity program designed to encourage and sustain regular exercise in men with prostate cancer. Despite known benefits, many prostate cancer patients are not sufficiently active, and this study aims to assess a combined approach involving personalized exercise plans, peer motivational support, and health professional guidance. The goal is to improve adherence to physical activity over a longer term than previous interventions, which typically lasted less than six months.
The study involves an experimental group receiving the Acti-Pair program, which includes motivational support from peers who meet WHO physical activity recommendations, personalized exercise projects supported by sport health centers, and prescriptions from general practitioners and physical activity professionals. The control group receives usual care, consisting of advice and recommendations to increase activity independently at home. The study is designed as a randomized, stepped-wedge trial.
Participants will be monitored over 12 months with objective and subjective measurements of physical activity, inactivity, physical capacity, muscle strength, fatigue levels, and quality of life assessed at multiple time points. The study also evaluates adherence, motivation, satisfaction, and the time health professionals and peers dedicate to the program. Outcomes include the cost-effectiveness of the intervention and factors influencing its implementation and sustainability.
CONDITIONS
Brief Title
Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients
Research Team
H
HUPIN DAVID, MD
A
Amandine BAUDOT, CRA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosed with prostate cancer for at least 1 year
Currently doing less than 150 minutes of physical activity per week
Affiliated or entitled to a social security scheme
Provided informed consent to participate in the study
You will not qualify if you...
Undergoing cancer treatment other than hormone therapy
Having serious heart, lung, or disabling joint conditions that prevent physical activity
Being deprived of liberty or under guardianship
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - 12 months
Participants engage in a physical activity intervention with motivational support from peers and health professionals to increase physical activity levels.
Visits at inclusion, 3, 6, and 12 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Study of 177Lu-PSMA as an Additional Treatment for High and Very High Risk Prostate Cancer After Radiation and Hormone Therapy
Phase 1b Study of 177Lu-PSMA-617 With Liver-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer
Using 18F-PSMA-1007 PET-CT to Guide Targeted Focal Therapy for MRI-Invisible Prostate Cancer
A Prospective Phase II Study Evaluating PET-Directed Treatment in Men with Localized Intermediate-Risk Prostate Cancer
Evaluation of 18F-PSMA-1007 PETCT Imaging Safety and Effectiveness in Adult Men with Prostate Cancer
Combining One MR-Guided HDR Brachytherapy and One SABR Treatment
for Favorable Risk Prostate Cancer
in a Phase 23 Study
Study of 4-Aminopyridine to Improve Nerve Recovery After Robot-Assisted Radical Prostatectomy in Men with Prostate Cancer
Phase III Study of 64Cu-GRIP B PET Imaging for Detecting Granzyme B in Adults with Advanced Genitourinary and Other Solid Tumors
Comparison of 68Ga-P16-093 and 68Ga-PSMA-11 PETCT Scans for Detecting Primary Prostate Cancer in Men
Using 68Ga-PSMA PETMRI and mpMRI to Detect Prostate Cancer in Men Aged 40 to 85
Observational Study to Compare Diagnostic Accuracy and Follow-Up Outcomes
PETCT Imaging Using 68Ga-RM26-RGD to Detect Breast, Brain, and Prostate Tumors with GRPR and v3 Receptors
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effects of a clinician referral and exercise program for men who have completed active treatment for prostate cancer: A multicenter cluster randomized controlled trial (ENGAGE).
Patricia M Livingston, Melinda J Craike, Jo Salmon...
Cancer survivors' exercise barriers, facilitators and preferences in the context of fatigue, quality of life and physical activity participation: a questionnaire-survey.